Indication
Angle-closure Glaucoma
1 clinical trial
2 products
Product
TravoprostClinical trial
A Twelve-Week, Double Masked, Parallel Group, Primary-Therapy Pilot Study of the Safety and Efficacy of Travoprost 0.004% Compared to Pilocarpine 1% in Patients With Chronic Angle-Closure GlaucomaStatus: Completed, Estimated PCD: 2008-05-01
Product
Pilocarpine